Free, soluble interleukin-17 protein during severe inflammation in human airways.
about
Selective regulatory function of Socs3 in the formation of IL-17-secreting T cellsInterleukin-17A mRNA and protein expression within cells from the human bronchoalveolar space after exposure to organic dust.Mechanisms underlying helper T-cell plasticity: implications for immune-mediated disease.Retinoid-related orphan receptor gamma t is a potential therapeutic target for controlling inflammatory autoimmunityNeutrophilic airway inflammation and IL-17.Serum amyloid A activates the NLRP3 inflammasome and promotes Th17 allergic asthma in mice.High- and low-dose allergen challenges in asthmatic patients using inhaled corticosteroids.FOXP3(+)Treg/Th17 cell imbalance in lung tissues of mice with asthma.Mast cell-derived TNF can promote Th17 cell-dependent neutrophil recruitment in ovalbumin-challenged OTII mice.IFN-γ synergistically enhances LPS signalling in alveolar macrophages from COPD patients and controls by corticosteroid-resistant STAT1 activation.A Novel Nuclear Function for the Interleukin-17 Signaling Adaptor Protein Act1.Airway epithelial regulation of allergic sensitization in asthma.Distinct, specific IL-17- and IL-22-producing CD4+ T cell subsets contribute to the human anti-mycobacterial immune responseEvaluation on the immunotherapy efficacies of synthetic peptide vaccines in asthmatic mice with group I and II allergens from Dermatophagoides pteronyssinusEffect of the Velvet Antler of Formosan Sambar Deer (Cervus unicolor swinhoei) on the Prevention of an Allergic Airway Response in Mice.Expression of interleukin-17 associated with disease progression and liver fibrosis with hepatitis B virus infection: IL-17 in HBV infection.The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease.Inhibition of lipopolysaccharide-stimulated chronic obstructive pulmonary disease macrophage inflammatory gene expression by dexamethasone and the p38 mitogen-activated protein kinase inhibitor N-cyano-N'-(2-{[8-(2,6-difluorophenyl)-4-(4-fluoro-2-meIL-12 can alleviate Th17-mediated allergic lung inflammation through induction of pulmonary IL-10 expressionEmerging roles of T helper subsets in the pathogenesis of asthma.IL-17A and Th17 cells in lung inflammation: an update on the role of Th17 cell differentiation and IL-17R signaling in host defense against infection.CD4+ T-cell subsets in inflammatory diseases: beyond the Th1/Th2 paradigm.ESAT-6- and CFP-10-specific Th1, Th22 and Th17 cells in tuberculous pleurisy may contribute to the local immune response against Mycobacterium tuberculosis infection.An investigation of the anti-inflammatory effects and a potential biomarker of PI3Kδ inhibition in COPD T cells.Interleukin-17 induces hyperresponsive interleukin-8 and interleukin-6 production to tumor necrosis factor-alpha in structural lung cells.Hog barn dust extract augments lymphocyte adhesion to human airway epithelial cells.Impact of tobacco smoking on cytokine signaling via interleukin-17A in the peripheral airways.Increased matrix metalloproteinase-9 concentration and activity after stimulation with interleukin-17 in mouse airways.Shifted T-cell polarisation after agricultural dust exposure in mice and men.Small interfering RNA targeting T-cell Ig mucin-3 decreases allergic airway inflammation and hyperresponsiveness.Impaired TNF/TNFR2 signaling enhances Th2 and Th17 polarization and aggravates allergic airway inflammation.
P2860
Q24547568-D5D85687-E23D-4894-8D6A-2B949BF21027Q24814904-3806E752-8448-4C5B-BA7C-C314C62FF63CQ27687830-205CD6C7-3463-4525-9D64-536768D7C116Q28302355-77889CD5-B46B-4BF2-9C34-DD846352E4FAQ34778056-8EE9DD44-77E2-4921-96F4-D97F6CE5548DQ35058983-C5E746A6-05C1-4CE2-9821-169091F1AE81Q35135980-0E19606A-5B50-47E2-A2C0-6A3C17731C02Q35643938-5BD97563-85CB-4A01-927A-BF5CCD443860Q35804444-C6CC17E7-A1F2-46F2-BE0C-F088A3AAFD53Q36110505-0EE64982-94A8-40ED-BA8E-8C858EF0BE34Q36159216-F5508000-7F1E-4105-9846-A2E1A5900D2DQ36183332-9F432A3D-5D16-407F-9A82-E5E1988E4C7DQ36416118-FBCD0F1C-B9CC-4198-B50B-CC96B15D1346Q36492730-7C35FA10-A710-44B5-9B8D-064603ACB318Q36531128-FE2A32D1-B0B2-4AE5-BE5E-000772D6FEBBQ36687453-A52B75B0-3F93-488F-BFFB-BD8440BF3C7CQ36747499-D2462A9D-D484-4DE3-9F26-A2CD7FDB30E5Q37192755-6500E2D8-AF95-406A-B4AF-497ADFACDCB9Q37276907-EA90590E-15BB-4F56-8CDB-DA9C1D73E64EQ37744925-6E71A35E-80F2-4202-A6A1-C221808435BBQ38129869-38D3EA17-9134-4577-A019-56FD88968A89Q38732306-C395B8C9-44DE-462F-95A2-3D49F9EC1191Q39373309-08CCCD70-EDC5-4081-BB16-8B6271416B60Q40211028-31B9BABE-D567-4786-AA50-46E8CDD4EC4BQ40432005-3730077A-7691-44B8-8BF0-368A0D1E98C5Q40598191-CA3386A8-BBDF-49A7-A20B-EDC5C51EDB3FQ41065779-B2AB86C0-3018-48F4-8132-37368BFF651EQ42264569-0C694964-7612-4C9E-893B-79BAA3D2F9EFQ44614757-4C8C3476-FADF-4642-B044-DC7CD66641D1Q45837452-118899C6-4F2C-449D-AA38-F8B72AAD9928Q47861312-080979F6-8528-4B3B-8B23-04810917043E
P2860
Free, soluble interleukin-17 protein during severe inflammation in human airways.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Free, soluble interleukin-17 protein during severe inflammation in human airways.
@ast
Free, soluble interleukin-17 protein during severe inflammation in human airways.
@en
Free, soluble interleukin-17 protein during severe inflammation in human airways.
@nl
type
label
Free, soluble interleukin-17 protein during severe inflammation in human airways.
@ast
Free, soluble interleukin-17 protein during severe inflammation in human airways.
@en
Free, soluble interleukin-17 protein during severe inflammation in human airways.
@nl
prefLabel
Free, soluble interleukin-17 protein during severe inflammation in human airways.
@ast
Free, soluble interleukin-17 protein during severe inflammation in human airways.
@en
Free, soluble interleukin-17 protein during severe inflammation in human airways.
@nl
P2093
P1476
Free, soluble interleukin-17 protein during severe inflammation in human airways.
@en
P2093
P304
P356
10.1183/09031936.02.00280902
P577
2002-03-01T00:00:00Z